TrialDiabetes, obesity & metabolism2021

A single-dose euglycaemic clamp study in two cohorts to compare the exposure of SAR341402 (insulin aspart) Mix 70/30 with US- and European-approved versions of insulin aspart Mix 70/30 and SAR341402 rapid-acting solution in subjects with type 1 diabetes.

Christoph Kapitza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.